Receptors, Lysophosphatidic Acid
"Receptors, Lysophosphatidic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subfamily of lysophospholipid receptors with specificity for LYSOPHOSPHATIDIC ACIDS.
| Descriptor ID |
D049368
|
| MeSH Number(s) |
D12.776.543.750.695.420.249
|
| Concept/Terms |
Receptors, Lysophosphatidic Acid- Receptors, Lysophosphatidic Acid
- Acid Receptors, Lysophosphatidic
- Lysophosphatidic Acid Receptors
- Lysophosphatidic Acid Receptor
- Acid Receptor, Lysophosphatidic
- LPA Receptors
- Receptors, LPA
- Receptor, Lysophosphatidic Acid
LPA2 Receptor- LPA2 Receptor
- Receptor, LPA2
- Edg-4 Receptor
- Edg 4 Receptor
- Receptor, Edg-4
- Edg4 Protein
LPA3 Receptor- LPA3 Receptor
- Receptor, LPA3
- Edg-7 Receptor
- Edg 7 Receptor
- Receptor, Edg-7
- EDG7 Protein
LPA1 Receptor- LPA1 Receptor
- Receptor, LPA1
- vzg-1 Receptor
- Receptor, vzg-1
- vzg 1 Receptor
- LPA-1 Receptor
- LPA 1 Receptor
- Edg2 Protein
- edg-2 Receptor
- Receptor, edg-2
- edg 2 Receptor
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Lysophosphatidic Acid".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Lysophosphatidic Acid".
This graph shows the total number of publications written about "Receptors, Lysophosphatidic Acid" by people in this website by year, and whether "Receptors, Lysophosphatidic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Lysophosphatidic Acid" by people in Profiles.
-
Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer. Cancer Lett. 2024 Jun 01; 591:216891.
-
Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts. Cancer Lett. 2019 02 01; 442:464-474.
-
Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3. Oncotarget. 2015 Nov 03; 6(34):36019-31.
-
The gep proto-oncogene Ga13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells. Pancreas. 2013 Jul; 42(5):819-28.
-
Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12. Oncogene. 2005 Jun 30; 24(28):4597-603.